ストックスクリーナーアプリを入手
8.75
1.74%
0.15
アフターアワーズ：
8.75
前日終値:
$8.60
開ける：
$8.59
24時間の取引高:
659.10K
Relative Volume:
1.22
時価総額：
$473.30M
収益：
$2.81M
当期純損益:
$-97.34M
株価収益率:
-5.538
EPS:
-1.58
ネットキャッシュフロー:
$-91.47M
1週間 パフォーマンス:
-5.10%
1か月 パフォーマンス:
-4.89%
6か月 パフォーマンス:
+127.27%
1年 パフォーマンス:
+176.90%
1日の値動き範囲:
$8.42
$9.15
1週間の範囲:
$8.29
$10.11
52週間の値動き範囲:
$2.315
$10.11
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
名前
Fulcrum Therapeutics Inc
セクター
電話
617-651-8851
住所
26 LANDSDOWNE STREET, CAMBRIDGE, MA
FULC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
8.75 | 465.19M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-29 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-09-12 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | ダウングレード | Stifel | Buy → Hold |
| 2024-09-09 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-05-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-09-25 | 開始されました | Goldman | Neutral |
| 2023-08-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | アップグレード | Stifel | Hold → Buy |
| 2023-05-04 | ダウングレード | Goldman | Buy → Neutral |
| 2023-03-10 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | ダウングレード | Stifel | Buy → Hold |
| 2023-02-28 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-11-15 | 開始されました | Goldman | Buy |
| 2022-03-08 | 開始されました | Oppenheimer | Outperform |
| 2022-03-03 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-08-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-03-22 | 開始されました | Credit Suisse | Outperform |
| 2021-03-02 | 開始されました | Stifel | Buy |
| 2020-10-16 | 開始されました | Piper Sandler | Overweight |
| 2020-08-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-08-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2019-10-03 | 開始されました | H.C. Wainwright | Buy |
| 2019-08-12 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Fulcrum Therapeutics Inc (FULC) 最新ニュース
Why Fulcrum Therapeutics Inc. stock is in analyst buy zone2025 Short Interest & Fast Gaining Stock Reports - newser.com
What risks investors should watch in Fulcrum Therapeutics Inc. stockMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Tick level data insight on Fulcrum Therapeutics Inc. volatilityMarket Movement Recap & Technical Entry and Exit Tips - newser.com
Will Fulcrum Therapeutics Inc. continue its uptrendQuarterly Profit Review & High Accuracy Swing Entry Alerts - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Stock Rating Lowered by Wall Street Zen - MarketBeat
Statistical indicators supporting Fulcrum Therapeutics Inc.’s strengthSell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Can Fulcrum Therapeutics Inc. stock resist sector downturnsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
How to track smart money flows in Fulcrum Therapeutics Inc.Market Activity Report & Reliable Volume Spike Alerts - newser.com
Will Fulcrum Therapeutics Inc. stock gain from strong economyMarket Activity Report & Fast Moving Trade Plans - newser.com
What is HC Wainwright's Estimate for FULC Q1 Earnings? - MarketBeat
Signal strength of Fulcrum Therapeutics Inc. stock in tech scannersTake Profit & Safe Capital Growth Trade Ideas - newser.com
How institutional buying supports Fulcrum Therapeutics Inc. stockJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Price Target Raised to $7.00 - MarketBeat
Published on: 2025-10-31 05:47:11 - newser.com
Fulcrum Therapeutics Inc. stock outlook for YEAR2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com
Is Fulcrum Therapeutics Inc. trending in predictive chart modelsBreakout Watch & High Return Trade Guides - newser.com
How sustainable is Fulcrum Therapeutics Inc. stock dividend payoutMarket Volume Report & Accurate Intraday Trade Tips - newser.com
How to forecast Fulcrum Therapeutics Inc. trends using time series - newser.com
Momentum divergence signals in Fulcrum Therapeutics Inc. chart2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com
Fulcrum Therapeutics Inc (FULC) Q3 2025 Earnings Call Highlights: Promising Advances in Sickle ... By GuruFocus - Investing.com Canada
Fulcrum Therapeutics Inc (FULC) Q3 2025 Earnings Call Highlights - GuruFocus
Fulcrum Therapeutics (FULC) Price Target Increased by 10.32% to 12.46 - MSN
RBC Capital Updates Fulcrum Therapeutics (FULC) Price Target Ami - GuruFocus
Fulcrum Therapeutics (NASDAQ:FULC) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Piper Sandler Raises Price Target on Fulcrum Therapeutics (FULC) - GuruFocus
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2025 Earnings Call Transcript - Insider Monkey
Fulcrum Therapeutics Inc. stock volume spike explainedWall Street Watch & Risk Managed Investment Signals - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Sets New 1-Year HighShould You Buy? - MarketBeat
Fulcrum Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat
Fulcrum Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Fulcrum Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Fulcrum Therapeutics Narrows Loss And Gains Wall Street Praise - Finimize
Fulcrum Therapeutics, Inc. (FULC) Q3 FY2025 earnings call transcript - Yahoo Finance
FULC's PIONEER Trial Shows Promising Results for Sickle Cell Tre - GuruFocus
Fulcrum Therapeutics Inc. (FULC) Misses Q3 EPS by 2c - StreetInsider
Fulcrum Therapeutics' Q3 net loss narrows - MarketScreener
Fulcrum Therapeutics : Corporate PresentationOctober 2025 - MarketScreener
Fulcrum Therapeutics Reports Positive Phase 1b PIONEER Trial Results for Pociredir in Sickle Cell Disease and Q3 2025 Financial Update - Quiver Quantitative
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025 - The Manila Times
FULC reports quarter ended Sept 30, 2025; Exhibit 99.1 furnished - Stock Titan
BRIEF-Fulcrum Therapeutics Q3 Basic EPS USD -0.31 - TradingView
Fulcrum Therapeutics Inc (FULC) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):